Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23

Become a member
  1. OncologyPRO
  2. Meeting Resources
  3. ESMO Congress 2022

The current and future of immunotherapy for metastatic NSCLC

Personalizing first-line immunotherapy: Beyond one size fits all

Date

12 Sep 2022

Session

The current and future of immunotherapy for metastatic NSCLC

Topics

Tumour Site

Non-Small Cell Lung Cancer

Presenters

Luis Paz-Ares

Authors

L. Paz-Ares

Author affiliations

  • Medical Oncology Department - Edificio Maternidad 2ª Planta, Hospital Universitario 12 de Octubre, 28041 - Madrid/ES

Resources

Login to get immediate access to this content.

If you do not have an ESMO account, please create one for free.

Login

Resources from the same session

Discussion

Presenter: All Speakers

Session: The current and future of immunotherapy for metastatic NSCLC

Resources:

Webcast

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings

  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.